Chairman & CEO of Edwards Lifesciences Corp (NYSE:EW) Michael A Mussallem sold 32,800 shares of EW on 03/08/2019 at an average price of $167.89 a share. The total sale was $5.5 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $35.98 billion; its shares were traded at around $173.17 with a P/E ratio of 51.23 and P/S ratio of 9.93. Edwards Lifesciences Corp had annual average EBITDA growth of 17.70% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star.
CEO Recent Trades:
Chairman & CEO Michael A Mussallem sold 32,800 shares of EW stock on 03/08/2019 at the average price of $167.89. The price of the stock has increased by 3.14% since.Chairman & CEO Michael A Mussallem sold 32,800 shares of EW stock on 02/12/2019 at the average price of $176.9. The price of the stock has decreased by 2.11% since.Directors and Officers Recent Trades:
CVP, TAVR Larry L Wood sold 6,716 shares of EW stock on 03/01/2019 at the average price of $170.82. The price of the stock has increased by 1.38% since.VP, Corporate Controller Robert W.a. Sellers sold 500 shares of EW stock on 02/22/2019 at the average price of $175.04. The price of the stock has decreased by 1.07% since.CVP, Critical Care Catherine M. Szyman sold 1,474 shares of EW stock on 02/21/2019 at the average price of $176.34. The price of the stock has decreased by 1.8% since.VP, Corporate Controller Robert W.a. Sellers sold 2,623 shares of EW stock on 02/21/2019 at the average price of $175.08. The price of the stock has decreased by 1.09% since.CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,500 shares of EW stock on 02/13/2019 at the average price of $177.75. The price of the stock has decreased by 2.58% since.For the complete insider trading history of EW, click here
.
No comments:
Post a Comment